Selected research
Industry Research
Fish-Oil Based Drugs Industry Research Report 2026
Market perspective
The global Fish-Oil Based Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fish-Oil Based Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fish-Oil Based Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fish-Oil Based Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fish-Oil Based Drugs include Aker Biomarine, BASF SE, Cellana, Clover Corporation, Croda International PLC, GC Rieber Oil, Omega Protein Corporation, Pharma Marine and Solutex GC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fish-Oil Based Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fish-Oil Based Drugs Market by Company
Aker Biomarine
BASF SE
Cellana
Clover Corporation
Croda International PLC
GC Rieber Oil
Omega Protein Corporation
Pharma Marine
Solutex GC
Stepan Company
United Laboratories
Fish-Oil Based Drugs Segment by Type
Salmon
Mackerel
Tuna
Herring
Others
Fish-Oil Based Drugs Segment by Application
Stroke
Dysmenorrhea
Rheumatoid Arthritis
Raynaud's Syndrome
Coronary Heart Disease (CHD)
Other
Fish-Oil Based Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fish-Oil Based Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fish-Oil Based Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fish-Oil Based Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fish-Oil Based Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fish-Oil Based Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fish-Oil Based Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Salmon
- Mackerel
- Tuna
- Herring
- Others
Applications
- Stroke
- Dysmenorrhea
- Rheumatoid Arthritis
- Raynaud's Syndrome
- Coronary Heart Disease (CHD)
- Other
Companies covered
- Aker Biomarine
- BASF SE
- Cellana
- Clover Corporation
- Croda International PLC
- GC Rieber Oil
- Omega Protein Corporation
- Pharma Marine
- Solutex GC
- Stepan Company
- United Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fish-Oil Based Drugs Market Size (2021-2032)
- 2.2.2 Global Fish-Oil Based Drugs Sales (2021-2032)
- 2.2.3 Global Fish-Oil Based Drugs Market Average Price (2021-2032)
- 2.3 Fish-Oil Based Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Salmon
- 2.3.3 Mackerel
- 2.3.4 Tuna
- 2.3.5 Herring
- 2.3.6 Others
- 2.4 Fish-Oil Based Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Stroke
- 2.4.3 Dysmenorrhea
- 2.4.4 Rheumatoid Arthritis
- 2.4.5 Raynaud's Syndrome
- 2.4.6 Coronary Heart Disease (CHD)
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fish-Oil Based Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fish-Oil Based Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Fish-Oil Based Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Fish-Oil Based Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Fish-Oil Based Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fish-Oil Based Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fish-Oil Based Drugs, Product Type & Application
- 3.8 Global Manufacturers of Fish-Oil Based Drugs, Established Date
- 3.9 Global Fish-Oil Based Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aker Biomarine
- 4.1.1 Aker Biomarine Company Information
- 4.1.2 Aker Biomarine Business Overview
- 4.1.3 Aker Biomarine Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aker Biomarine Fish-Oil Based Drugs Product Portfolio
- 4.1.5 Aker Biomarine Recent Developments
- 4.2 BASF SE
- 4.2.1 BASF SE Company Information
- 4.2.2 BASF SE Business Overview
- 4.2.3 BASF SE Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BASF SE Fish-Oil Based Drugs Product Portfolio
- 4.2.5 BASF SE Recent Developments
- 4.3 Cellana
- 4.3.1 Cellana Company Information
- 4.3.2 Cellana Business Overview
- 4.3.3 Cellana Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cellana Fish-Oil Based Drugs Product Portfolio
- 4.3.5 Cellana Recent Developments
- 4.4 Clover Corporation
- 4.4.1 Clover Corporation Company Information
- 4.4.2 Clover Corporation Business Overview
- 4.4.3 Clover Corporation Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Clover Corporation Fish-Oil Based Drugs Product Portfolio
- 4.4.5 Clover Corporation Recent Developments
- 4.5 Croda International PLC
- 4.5.1 Croda International PLC Company Information
- 4.5.2 Croda International PLC Business Overview
- 4.5.3 Croda International PLC Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Croda International PLC Fish-Oil Based Drugs Product Portfolio
- 4.5.5 Croda International PLC Recent Developments
- 4.6 GC Rieber Oil
- 4.6.1 GC Rieber Oil Company Information
- 4.6.2 GC Rieber Oil Business Overview
- 4.6.3 GC Rieber Oil Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GC Rieber Oil Fish-Oil Based Drugs Product Portfolio
- 4.6.5 GC Rieber Oil Recent Developments
- 4.7 Omega Protein Corporation
- 4.7.1 Omega Protein Corporation Company Information
- 4.7.2 Omega Protein Corporation Business Overview
- 4.7.3 Omega Protein Corporation Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Omega Protein Corporation Fish-Oil Based Drugs Product Portfolio
- 4.7.5 Omega Protein Corporation Recent Developments
- 4.8 Pharma Marine
- 4.8.1 Pharma Marine Company Information
- 4.8.2 Pharma Marine Business Overview
- 4.8.3 Pharma Marine Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pharma Marine Fish-Oil Based Drugs Product Portfolio
- 4.8.5 Pharma Marine Recent Developments
- 4.9 Solutex GC
- 4.9.1 Solutex GC Company Information
- 4.9.2 Solutex GC Business Overview
- 4.9.3 Solutex GC Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Solutex GC Fish-Oil Based Drugs Product Portfolio
- 4.9.5 Solutex GC Recent Developments
- 4.10 Stepan Company
- 4.10.1 Stepan Company Company Information
- 4.10.2 Stepan Company Business Overview
- 4.10.3 Stepan Company Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Stepan Company Fish-Oil Based Drugs Product Portfolio
- 4.10.5 Stepan Company Recent Developments
- 4.11 United Laboratories
- 4.11.1 United Laboratories Company Information
- 4.11.2 United Laboratories Business Overview
- 4.11.3 United Laboratories Fish-Oil Based Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 United Laboratories Fish-Oil Based Drugs Product Portfolio
- 4.11.5 United Laboratories Recent Developments
5 Global Fish-Oil Based Drugs Market Scenario by Region
- 5.1 Global Fish-Oil Based Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fish-Oil Based Drugs Sales by Region: 2021-2032
- 5.2.1 Global Fish-Oil Based Drugs Sales by Region: 2021-2026
- 5.2.2 Global Fish-Oil Based Drugs Sales by Region: 2027-2032
- 5.3 Global Fish-Oil Based Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Fish-Oil Based Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Fish-Oil Based Drugs Revenue by Region: 2027-2032
- 5.4 North America Fish-Oil Based Drugs Market Facts & Figures by Country
- 5.4.1 North America Fish-Oil Based Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fish-Oil Based Drugs Sales by Country (2021-2032)
- 5.4.3 North America Fish-Oil Based Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Fish-Oil Based Drugs Market Facts & Figures by Country
- 5.5.1 Europe Fish-Oil Based Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fish-Oil Based Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Fish-Oil Based Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Fish-Oil Based Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fish-Oil Based Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fish-Oil Based Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fish-Oil Based Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fish-Oil Based Drugs Market Facts & Figures by Country
- 5.7.1 South America Fish-Oil Based Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fish-Oil Based Drugs Sales by Country (2021-2032)
- 5.7.3 South America Fish-Oil Based Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Fish-Oil Based Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fish-Oil Based Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fish-Oil Based Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fish-Oil Based Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Fish-Oil Based Drugs Sales by Type (2021-2032)
- 6.1.1 Global Fish-Oil Based Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Fish-Oil Based Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Fish-Oil Based Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Fish-Oil Based Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fish-Oil Based Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Fish-Oil Based Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fish-Oil Based Drugs Sales by Application (2021-2032)
- 7.1.1 Global Fish-Oil Based Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Fish-Oil Based Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Fish-Oil Based Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Fish-Oil Based Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fish-Oil Based Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Fish-Oil Based Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fish-Oil Based Drugs Value Chain Analysis
- 8.1.1 Fish-Oil Based Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fish-Oil Based Drugs Production Mode & Process
- 8.2 Fish-Oil Based Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fish-Oil Based Drugs Distributors
- 8.2.3 Fish-Oil Based Drugs Customers
9 Global Fish-Oil Based Drugs Analyzing Market Dynamics
- 9.1 Fish-Oil Based Drugs Industry Trends
- 9.2 Fish-Oil Based Drugs Industry Drivers
- 9.3 Fish-Oil Based Drugs Industry Opportunities and Challenges
- 9.4 Fish-Oil Based Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst